Dermira to Present Data for DRM01 Acne Program at 45th Annual ESDR Meeting
September 03, 2015 07:30 ET
|
Dermira, Inc.
MENLO PARK, Calif., Sept. 3, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists...
Dermira Reports Second Quarter 2015 Financial Results and Provides Corporate Update
August 13, 2015 16:15 ET
|
Dermira, Inc.
Two Product Candidates Now in Phase 3 Development
Approximately $104 Million in Net Proceeds From Recent Follow-on Public Offering
MENLO PARK, Calif., Aug. 13, 2015 (GLOBE NEWSWIRE) -- Dermira,...
Dermira Announces Closing of Follow-on Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
August 11, 2015 16:05 ET
|
Dermira, Inc.
MENLO PARK, Calif., Aug. 11, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists...
Dermira Prices Follow-On Public Offering of Common Stock
August 05, 2015 20:29 ET
|
Dermira, Inc.
MENLO PARK, Calif., Aug. 5, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and...
Dermira Commences Follow-on Public Offering of Common Stock
August 04, 2015 16:01 ET
|
Dermira, Inc.
MENLO PARK, Calif., Aug. 4, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and...
Dermira Doses First Patients in DRM04 Phase 3 Program in Axillary Hyperhidrosis
August 03, 2015 07:30 ET
|
Dermira, Inc.
Two Identical Studies to Enroll a Combined Total of 660 Patients
Topline Phase 3 Data Expected in the Second Half of 2016
Represents Dermira's Second Product Candidate in Phase 3...
Dermira's Phase 2a DRM01 Acne Trial Data Presented at the World Congress of Dermatology Meeting
June 09, 2015 07:30 ET
|
Dermira, Inc.
MENLO PARK, Calif., June 9, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and...
Dermira Announces Poster Presentation on DRM01 in Acne at World Congress of Dermatology
June 02, 2015 07:30 ET
|
Dermira, Inc.
MENLO PARK, Calif., June 2, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and...
Dermira to Present at Jefferies 2015 Global Healthcare Conference
May 28, 2015 07:30 ET
|
Dermira, Inc.
MENLO PARK, Calif., May 28, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and...
Dermira Reports First Quarter 2015 Financial Results and Provides Corporate Update
May 12, 2015 16:13 ET
|
Dermira, Inc.
MENLO PARK, Calif., May 12, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and...